Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation

Background Immune checkpoint inhibitors (ICIs) are being used after allogeneic hematopoietic stem cell transplantation (alloHCT) to reverse immune dysfunction. However, a major concern for the use of ICIs after alloHCT is the increased risk of graft-versus-host disease (GVHD). We analyzed the associ...

Full description

Bibliographic Details
Published in:Journal for ImmunoTherapy of Cancer
Main Authors: Maro Ohanian, Farhad Ravandi, Maria E Suarez-Almazor, Adi Diab, Noha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, Marina Konopleva, Stephen Gruschkus, Chantal Saberian, May Daher, Richard Champlin, Kaysia Ludford, Gheath Al-Atrash, Guillermo Garcia-Manero, Naval Daver, Hind Rafei, Jacinth Joseph, Gabriela Rondon, Laura Whited, Faisal Fa'ak, Cristina Knape, Mahran Shoukier, Megan Marcotulli, Alison M Gulbis, Betul Oran, Uday R Popat, Rotesh Mehta, Amin M Alousi
Format: Article
Language:English
Published: BMJ Publishing Group 2021-02-01
Online Access:https://jitc.bmj.com/content/9/2/e001818.full

Similar Items

Similar Items